Barry Antonacci

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i>

Anthony Cacciapuoti, David Loebenberg, Erik Corcoran et al. · Antimicrobial Agents and Chemotherapy · 2000 · 99 citations · Full text

Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors

Scott S. Walker, Yiming Xu, Ilias Triantafyllou et al. · Antimicrobial Agents and Chemotherapy · 2011 · 75 citations · Full text

Medicinal Chemistry, Antifungal Agent, Biochemistry +11

In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304

David Loebenberg, Anthony Cacciapuoti, Raulo Parmegiani et al. · Antimicrobial Agents and Chemotherapy · 1992 · 22 citations

Sch 42426, Medicinal Chemistry, Antifungal Agent +14

Relationship Among Physicochemical Properties, Skin Permeability, and Topical Activity of the Racemic Compound and Pure Enantiomers of a New Antifungal

Lorraine Wearley, Barry Antonacci, Anthony Cacciapuoti et al. · Pharmaceutical Research · 1993 · 18 citations

Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B

Raulo Parmegiani, David Loebenberg, Barry Antonacci et al. · Antimicrobial Agents and Chemotherapy · 1987 · 15 citations

Medicinal Chemistry, Pharmaceutical Science, Antifungal Agent +14